Research Options:
Select below
IPO Calendar
Week of Expected Pricing
Withdrawn
Company Name
VIAMET PHARMACEUTICALS HOLDINGS LLC
Proposed Ticker
VMET
CUSIP
N/A
Business Description
A biopharmaceutical company focused on the discovery, development and commercialization of novel antifungal agents based on our proprietary metalloenzyme medicinal chemistry platform, which we call our MetallophileŽ Technology.
Lead Underwriter
Goldman, Sachs & Co,Morgan Stanley & Co. LLC
Co-Managers
Guggenheim Securities,LLC,Needham & Company, LLC
Initial Shares
5,700,000
Revised Initial Shares
N/A
Initial Price
$14.00-$16.00
Revised Price
N/A
Final Price
N/A
Final Ticker
N/A
© 2024 ICE Data Services. All rights reserved.
